NAD+: A key metabolic regulator with great therapeutic potential
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Accepteret manuskript, 289 KB, PDF-dokument
Nicotinamide adenine dinucleotide (NAD+) is a ubiquitous metabolite that serves an essential role in the catabolism of nutrients. Recently, there has been a surge of interest in NAD+ biology, with the recognition that NAD+ influences many biological processes beyond metabolism, including transcription, signalling and cell survival. There are a multitude of pathways involved in the synthesis and breakdown of NAD+, and alterations in NAD+ homeostasis have emerged as a common feature of a range of disease states. Here, we provide an overview of NAD+ metabolism and summarise progress on the development of NAD+-related therapeutics.
Originalsprog | Engelsk |
---|---|
Artikelnummer | e12508 |
Tidsskrift | Journal of Neuroendocrinology |
Vol/bind | 29 |
Udgave nummer | 10 |
ISSN | 0953-8194 |
DOI | |
Status | Udgivet - 2017 |
Eksternt udgivet | Ja |
Bibliografisk note
Publisher Copyright:
© 2017 British Society for Neuroendocrinology
ID: 322908691